HCL Technologies Limited (NSEI:HCLTECH) is in talks to pick up a 10% stake worth around INR 7,000 million to INR 7,500 million in BDR Pharmaceuticals International, two persons familiar with the development told VCCircle. The said transaction is likely to value the Mumbai-based pharmaceuticals firm at around INR 70,000 million - INR 75,000 million. HCL is said to be evaluating the transaction through its subsidiary HCL Capital, the individuals cited above spoke on condition of anonymity.

Email queries sent to HCL Technologies and BDR Pharmaceuticals International went unanswered till press time.